Michael Savin, MD

Research Reports

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting

02/15/2018

Casey Mason

Peter G Ellis, MD

Kathy Lokay

Amanda Barry, MPH

Natalie Dickson, MD

Ray Page, DO, PhD

Blase Polite, MD

Ravi Salgia, MD, PhD

Michael Savin, MD

Corey Shamah, MD

Mark A Socinski, MD

Abstract: Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non–small cell lung cancer (NSCLC), there...

...

02/15/2018

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

May 28 ⁠–⁠ May 31

May 30 ⁠–⁠ June 2

May 30 ⁠–⁠ June 1

June 7

June 8 ⁠–⁠ June 9

June 20 ⁠–⁠ June 21

June 21 ⁠–⁠ June 22

July 3 ⁠–⁠ July 6

July 18 ⁠–⁠ July 19

July 19 ⁠–⁠ July 20

See Full Calendar

Michael Savin, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products